Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Genzyme’s Woes Piling Up as FDA Panel Says Data on Leukemia Drug are Lacking
|
Luke Timmerman |
09/01/09 |
Boston
|
|
Genzyme Asks FDA To Approve Drug for Acute Myeloid Leukemia
|
Luke Timmerman |
11/24/08 |
Boston
|
|
Lies, Damned Lies, and Statistics: The Definitive Rundown on New England Biotech
|
Gregory T. Huang |
05/23/08 |
Boston
|
|
The Xconomy Half-Dozen-Stories-of-the-Half-Year Awards
|
Rebecca Zacks |
12/27/07 |
Boston
|
|
Genzyme Comes Back to Win Bioenvision Vote—Disputed Merger to Go Forward
|
Robert Buderi |
10/22/07 |
Boston
|
|
Hologic Faces Lawsuit, OLPC Chooses a Distributor, Point Therapeutics Agrees to a Reverse Merger, and More
|
Rebecca Zacks |
10/15/07 |
Boston
|
|
Genzyme and Bioenvision Win Court’s Permission to Reopen Voting on Troubled Merger Agreement
|
Rebecca Zacks |
10/10/07 |
Boston
|
|
Still No Conclusion to Genzyme-Bioenvision Saga
|
Rebecca Zacks |
10/05/07 |
Boston
|
|
Genzyme Takeover Bid for Bioenvision Still Alive as Special Session Adjourns For the Day
|
Robert Buderi |
10/04/07 |
Boston
|
|
Genzyme to Bioenvision Board: Acquisition Offer Price Will Not be Raised
|
Rebecca Zacks |
09/27/07 |
Boston
|
|
Saying Bioenvision is Poised for a “Home Run,” Investor Files New Challenge to Genzyme Takeover Bid
|
Robert Buderi |
09/12/07 |
Boston
|
|
Another Voice Heard in the Genzyme-Bioenvision Takeover Debate: Elliot Associates is “Extremely Dissatisfied”
|
Rebecca Zacks |
09/06/07 |
Boston
|
|
Former Bioenvision Exec Sues for $108 Million; Genzyme Biding Its Time on Takeover
|
Robert Buderi |
08/23/07 |
Boston
|
|
Special Vote Called for on Genzyme’s Takeover Bid for Bioenvision: Is a Deal in the Works?
|
Robert Buderi |
08/20/07 |
Boston
|
|
Good News for Genzyme, Bad News for Boston Scientific, and all the Other News We Didn’t Get to This Week
|
Rebecca Zacks |
08/03/07 |
Boston
|
|
Bioenvision Update: Merger Foe Stops Blogging After Genzyme Subpoena; Board Battle Continues
|
Robert Buderi |
07/25/07 |
Boston
|
|
Christopher Wood: Step Up, Then Step Down
|
Robert Buderi |
07/18/07 |
Boston
|
|
Genzyme Fires Back, Says It Will Block Addition of New Bioenvision Board Members
|
Robert Buderi |
07/17/07 |
Boston
|
|
Shake Up at Bioenvision: Two Board Members Resign
|
Robert Buderi |
07/16/07 |
Boston
|
|
Who’s Cashing in on Bioenvision Sale to Genzyme: The List
|
Robert Buderi |
07/13/07 |
Boston
|
|
Bioenvison Shareholder Calls for New Board, Revocation of Genzyme’s License
|
Robert Buderi |
07/11/07 |
Boston
|
|
No New Shares Tendered in Bioenvision Deal; Genzyme Still Hopes for Merger
|
Robert Buderi |
07/10/07 |
Boston
|
|
Genzyme’s Second Try for Bioenvision Will Also Fail, Sources Predict; Institutional Investors Seek Higher Price
|
Robert Buderi |
07/09/07 |
Boston
|
|
Genzyme Takeover of Bioenvision Falls Short; Company Tries New Tack
|
Robert Buderi |
07/02/07 |
Boston
|
|
Genzyme Takeover Deal Will Fail, Predicts Bioenvision Shareholder
|
Robert Buderi |
06/29/07 |
Boston
|
|
A Deal Too True to be Good? Shareholder Uprising Aims to Disrupt Genzyme’s Takeover Plans
|
Robert Buderi |
06/07/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
